SMC
TMO icon

Smith, Moore & Co’s Thermo Fisher Scientific TMO Stock Holding History

Smith, Moore & Co’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Sell
562
-2
-0.4% -$960 0.02% 477
2026
Q1 		$277K Sell
564
-9
-2% -$4.88K 0.02% 463
2025
Q4 		$332K Sell
573
-5
-0.9% -$2.83K 0.03% 396
2025
Q3 		$281K Buy
578
+2
+0.3% +$931 0.02% 422
2025
Q2 		$234K Buy
576
+3
+0.5% +$1.25K 0.02% 448
2025
Q1 		$285K Buy
+573
New +$310K 0.03% 387
2023
Q3 		– Sell
-1,711
Closed -$893K – 400
2023
Q2 		$893K Buy
1,711
+44
+3% +$23.7K 0.11% 164
2023
Q1 		$961K Buy
1,667
+95
+6% +$53.5K 0.13% 145
2022
Q4 		$866K Buy
1,572
+77
+5% +$40.8K 0.12% 163
2022
Q3 		$758K Buy
1,495
+81
+6% +$45.3K 0.12% 165
2022
Q2 		$768K Buy
1,414
+61
+5% +$33.6K 0.12% 174
2022
Q1 		$799K Hold
1,353
– – 0.11% 187
2021
Q4 		$903K Buy
1,353
+85
+7% +$53.1K 0.13% 168
2021
Q3 		$725K Sell
1,268
-72
-5% -$39.5K 0.11% 187
2021
Q2 		$676K Buy
1,340
+13
+1% +$6.13K 0.1% 201
2021
Q1 		$606K Sell
1,327
-35
-3% -$16.7K 0.1% 206
2020
Q4 		$634K Sell
1,362
-132
-9% -$61.9K 0.12% 176
2020
Q3 		$660K Sell
1,494
-15
-1% -$6.2K 0.14% 150
2020
Q2 		$547K Sell
1,509
-202
-12% -$67.7K 0.12% 156
2020
Q1 		$485K Buy
1,711
+118
+7% +$37.2K 0.13% 154
2019
Q4 		$518K Sell
1,593
-47
-3% -$14.3K 0.11% 171
2019
Q3 		$478K Buy
1,640
+54
+3% +$15.5K 0.11% 177
2019
Q2 		$466K Buy
1,586
+7
+0.4% +$1.93K 0.1% 190
2019
Q1 		$432K Sell
1,579
-89
-5% -$22.1K 0.1% 197
2018
Q4 		$373K Buy
1,668
+311
+23% +$73K 0.1% 202
2018
Q3 		$331K Sell
1,357
-31
-2% -$7.13K 0.08% 234
2018
Q2 		$288K Buy
1,388
+179
+15% +$38K 0.07% 247
2018
Q1 		$250K Buy
+1,209
New +$254K 0.07% 259

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Smith, Moore & Co's TMO Position: Q2 2026 in Review

Smith, Moore & Co reduced its Thermo Fisher Scientific (TMO) stake by 0.35% in Q2 2026, selling an estimated $960 and leaving 562 shares worth $282K. The position accounts for 0.02% of the portfolio, ranked #477.

Smith, Moore & Co first reported a position in TMO in Q1 2018 and has held it in 28 quarters since. The position peaked at $961K in Q1 2023. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Smith, Moore & Co held 562 shares of Thermo Fisher Scientific worth $282K as of Q2 2026.
  • Smith, Moore & Co sold 2 Thermo Fisher Scientific shares in Q2 2026, an estimated $960.
  • Thermo Fisher Scientific made up 0.02% of Smith, Moore & Co's portfolio in Q2 2026, its #477 holding.
  • Smith, Moore & Co first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 28 quarters since.
  • Smith, Moore & Co's Thermo Fisher Scientific position peaked at $961K in Q1 2023.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Smith, Moore & Co's 13F filing for Q2 2026, filed 12 Aug 2026.